Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the SB 551 Shield Law For Reproductive Health topic

No spam. Unsubscribe anytime.

Senate Committee Hears SB 551, Shield‑law Proposal to Protect Reproductive‑health Providers from Out‑of‑State Suits

New Hampshire Senate Judiciary Committee · February 11, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senate Bill 551 would limit New Hampshire cooperation with out‑of‑state investigations or civil enforcement tied to reproductive health care provided lawfully in New Hampshire. Supporters, including OB‑GYN residents, said the bill protects providers and access; opponents raised interstate‑comity and fiscal concerns.

Senate Bill 551 would create statutory protections for patients and providers who obtain or provide reproductive‑health care lawfully in New Hampshire, sponsors said. Senator Deborah Altschuler told the Judiciary Committee the measure is a ‘‘shield law’’ designed to protect providers from abusive out‑of‑state litigation and to preserve New Hampshire's authority over care provided within its borders.

Physicians and trainees described clinic‑level consequences if the state lacks protections. Dr. Carrie Wong, an OB‑GYN resident at Dartmouth‑Hitchcock, said the absence of a shield law influences where young doctors choose to practice and that some clinicians have already left more restrictive states. "I'm not convinced New Hampshire is still the state for me" absent protection, she said.

Advocacy groups (ACLU of New Hampshire, Reproductive Equity Now) urged the committee to pass the bill as narrowly drafted to avoid full‑faith‑and‑credit conflicts and to limit cooperation only with out‑of‑state investigations tied to conduct that is lawful here. Supporters said the bill is consistent with longstanding federalism principles and would protect patient privacy and access.

Opponents raised constitutional and practical concerns about interstate enforcement and potential effects on civil‑judgment compacts, and some cautioned about unknown fiscal impacts. Jason Hennessy, representing a pro‑life organization, argued the proposal singled out reproductive care for special treatment and could reduce interstate cooperation on enforcement.

Committee members asked technical questions about whether the bill would prevent enforcing final out‑of‑state judgments and how the text interacts with existing interstate compacts. Sponsors and supporting lawyers said the bill was tailored to limit cooperation with out‑of‑state investigations and not to invalidate ordinary final judgments.

The committee closed the hearing after receiving several hours of testimony; no vote was recorded in the transcript.